home All News open_in_new Full Article

Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants

VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and convertible debentures of the Company, as further described herein. Convertible Debenture Amendments The Company intends to file an application […]


today 7 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Other
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Other


ID: 264359354
Add Watch Country

arrow_drop_down